UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.428

Sortiert nach

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome

Nature Medicine, 2022-01, Vol.28 (1), p.71-80

2022

Volltextzugriff (PDF)

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-10, Vol.28 (10), p.2217-2217

2022

Volltextzugriff (PDF)

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Leukemia, 2011-09, Vol.25 (9), p.1471-1483

2011

Volltextzugriff (PDF)

Translational Mini‐Review Series on Immunodeficiency: Molecular defects in common variable immunodeficiency

Clinical and experimental immunology, 2007-09, Vol.149 (3), p.401-409

2007

Volltextzugriff (PDF)

Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS

Gene therapy, 2009-05, Vol.16 (5), p.605-619

2009

Volltextzugriff (PDF)

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients

Gene therapy, 2007-03, Vol.14 (5), p.415-428

2007

Volltextzugriff (PDF)

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

Gene therapy, 2012-03, Vol.19 (3), p.246-254

2012

Volltextzugriff (PDF)

Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors

Gene therapy, 2009-04, Vol.16 (4), p.509-520

2009

Volltextzugriff (PDF)

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

Gene therapy, 2002-03, Vol.9 (5), p.320-326

2002

Volltextzugriff (PDF)

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

Gene therapy, 2005-04, Vol.12 (8), p.694-701

2005

Volltextzugriff (PDF)

Neonatal dendritic cells are intrinsically biased against Th‐1 immune responses

Clinical and experimental immunology, 2002-04, Vol.128 (1), p.118-123

2002

Volltextzugriff (PDF)

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Gene therapy, 2012-08, Vol.19 (8), p.872-876

2012

Volltextzugriff (PDF)

Chronic granulomatous disease

Clinical and experimental immunology, 2000-10, Vol.122 (1), p.1-9

2000

Volltextzugriff (PDF)

Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression

Gene therapy, 2008-08, Vol.15 (16), p.1167-1175

2008

Volltextzugriff (PDF)

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

Leukemia, 2007-04, Vol.21 (4), p.754-763

2007

Volltextzugriff (PDF)

Genetic Variants Associated With Neutrophil Function in Aggressive Periodontitis and Healthy Controls

Journal of periodontology (1970), 2010-04, Vol.81 (4), p.527-534

2010

Volltextzugriff (PDF)

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

Gene therapy, 2001-11, Vol.8 (21), p.1665-1668

2001

Volltextzugriff (PDF)

Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences

Gene therapy, 2005-04, Vol.12 (8), p.715-723

2005

Volltextzugriff (PDF)

Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy

Nature genetics, 2000-07, Vol.25 (3), p.306-310

2000

Volltextzugriff (PDF)

Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome

British journal of haematology, 1998-06, Vol.101 (4), p.659-665

1998

Volltextzugriff (PDF)

Correction of SCID-X1 using an enhancerless Vav promoter

Human gene therapy, 2011-03, Vol.22 (3), p.263

2011

Volltextzugriff (PDF)

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency

British journal of haematology, 2007-07, Vol.138 (1), p.94-96

2007

Volltextzugriff (PDF)

Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX

Gene therapy, 2006-01, Vol.13 (2), p.117-126

2006

Volltextzugriff (PDF)

The Wiskott-Aldrich syndrome

Journal of Allergy and Clinical Immunology, 2006-04, Vol.117 (4), p.725-738

2006

Volltextzugriff (PDF)

Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis

Blood, 2000-05, Vol.95 (9), p.2943-2946

2000

Volltextzugriff (PDF)

1 – 25 von 1.428

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.223)
Mit Volltextzugriff
(1.075)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(847)
Life Sciences & Biomedicine
(720)
Humans
(582)
Animals
(319)
Male
(298)
Biological And Medical Sciences
(272)
Medical Sciences
(218)
Female
(210)
Gene Therapy
(190)
Mice
(180)
Medicine, Research & Experimental
(143)
Research & Experimental Medicine
(143)
Adult
(133)
Biotechnology & Applied Microbiology
(124)
Immunology
(121)
Middle Aged
(120)
Genetics & Heredity
(116)
Hematology
(97)
Fundamental And Applied Biological Sciences. Psychology
(95)
Physical Sciences
(95)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Translational Mini‐Review Series on Immunodeficiency: Molecular defects in common variable immunodeficiency

Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

Neonatal dendritic cells are intrinsically biased against Th‐1 immune responses

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Chronic granulomatous disease

Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

Genetic Variants Associated With Neutrophil Function in Aggressive Periodontitis and Healthy Controls

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences

Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy

Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome

Correction of SCID-X1 using an enhancerless Vav promoter

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency

Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX

The Wiskott-Aldrich syndrome

Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis

Aktive Filter

Suchergebnisse filtern